Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia
Joint Authors
Butt, Muhammad Umer
Jabri, Ahmad
Elayi, Samy Claude
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-07-08
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Drug-induced thrombocytopenia requires a high suspicion for diagnosis and a broad investigation to exclude other etiologies of low platelets.
Cessation of the offending agent often results in recovery of platelet counts.
Many medications are known to cause a degree of thrombocytopenia.
We present a rare case of severe thrombocytopenia associated with administration of azithromycin.
American Psychological Association (APA)
Butt, Muhammad Umer& Jabri, Ahmad& Elayi, Samy Claude. 2019. Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia. Case Reports in Medicine،Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1140923
Modern Language Association (MLA)
Butt, Muhammad Umer…[et al.]. Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia. Case Reports in Medicine No. 2019 (2019), pp.1-3.
https://search.emarefa.net/detail/BIM-1140923
American Medical Association (AMA)
Butt, Muhammad Umer& Jabri, Ahmad& Elayi, Samy Claude. Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia. Case Reports in Medicine. 2019. Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1140923
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1140923